Semaglutide vs quit-smoking aids Semaglutide provides complementary benefits over traditional quit-smoking aids which have been in use in recent years such as nicotine replacement therapy (NRT), bupropion etc
Vendors offering only "in-house testing" are commonly distrusted
Effects of regular physical activity on the immune system, vaccination and risk of community-acquired infectious disease in the general population: systematic review and meta-analysis
Handling : Use standard laboratory safety procedures and dispose of materials in accordance with institutional regulations
Based on early human studies and animal research, GLP-1 agonists may affect: Reward-related eating behaviours by potentially modulating dopamine signalling in brain reward circuits Food cravings and hedonic eating (eating for pleasure rather than hunger) Impulsivity around food , possibly reducing the compulsive aspects of eating Satiety signalling , enhancing the feeling of fullness after meals Some patients using GLP-1 medications for diabetes or weight management report not just reduced appetite but also diminished preoccupation with food, fewer intrusive thoughts about eating, and reduced cravings for specific foods, particularly those high in fat and sugar
Comparison of registered and published primary outcomes in randomized controlled trials
